Schmid Summarizes Updates in HER2-Positive Breast Cancer Management
Dr Schmid discusses considerations for applying recent data updates in HER2-positive breast cancer management to clinical practice.
Source: onclive.com
Peter Schmid News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Peter Schmid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Peter Schmid Today - Breaking & Trending Today
PUMA's Sneaker Archive Is Truly Wild
PUMA's sneaker archive is filled with left-field shoes that are starting to get the attention they deserve. We deep-dived into some of its most wild sneakers.
Source: highsnobiety.com
Neoadjuvant/Adjuvant Pembrolizumab Regimen Continues to Show EFS Benefit in High-Risk Early TNBC
The 5-year event-free survival EFS) rate was 81.3% with neoadjuvant pembrolizumab/chemotherapy followed by adjuvant pembrolizumab compared with 72.3% in those who received placebo/chemotherapy plus placebo.
Source: ajmc.com
Biometrics, digital ID advisory board changes announced in Scotland, US, Germany
Biometrics and digital ID security companies in the U.S. and Germany have announced the appointment of new members to advisory roles.
Source: biometricupdate.com
Conference Highlights from SABCS
CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.
Source: curetoday.com